ALVEOLAR SOFT PART SARCOMA
Clinical trials for ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Canadian trial tests engineered immune cells to fight tough cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of personalized immune cell therapy called GCAR1 in people with advanced cancers that have stopped responding to standard treatments. The main goal is to find the safest and most effective dose of GCAR1 for patients with specific types…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
One patient, one hope: Custom-Made immune cells battle rare cancer
Disease control Not yet recruitingThis is a single-patient study for someone with advanced alveolar soft part sarcoma, a rare cancer, that has progressed despite other treatments. The study will test a personalized therapy called GCAR1, which involves modifying the patient's own immune cells to attack their cance…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: EARLY_PHASE1 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC